Navigation Links
Codexis Board Elects Pedro I. Mizutani, Raizen EVP, as Director
Date:7/28/2011

REDWOOD CITY, Calif., July 28, 2011 /PRNewswire/ -- Codexis, Inc. (Nasdaq: CDXS) today announced that Pedro I. Mizutani, Executive Vice President, Upstream Business, Raizen Energia Participacoes S.A, has been elected to the Codexis Board of Directors. Mr. Mizutani serves as the Board representative of Raizen, Brazil's largest sugar and ethanol producer. Raizen holds approximately 16% of Codexis' outstanding shares of common stock and is the company's largest stockholder.

"We are delighted to have Pedro Mizutani join our Board," said Alan Shaw, Ph.D., President and Chief Executive Officer. "He brings a wealth of executive experience in industrial, financial and agricultural operations, as well as an in-depth knowledge of the Brazilian fuels and sugar markets. Mr. Mizutani is widely known and respected in the Brazilian business community, and his deep industry knowledge and strategic counsel will bring immediate value to Codexis."

Mr. Mizutani joined Raizen in June 2011 and has responsibility for all upstream business (production of sugar, ethanol, and bioenergy). From 2000-2010, he was Director at Cosan Group with responsibility for all upstream production, and in 2010 was appointed CEO of Cosan Sugar and Ethanol. Cosan is one of the largest groups in Brazil, with businesses in energy, food, logistics, infrastructure and agricultural property management.

He holds a degree in production engineering from the University of Sao Paulo, an MBA from the Getulio Vargas Foundation and a post-graduate degree in finance from the Methodist University of Piracicaba. He has also attended extension courses in business management at Ohio University and the Kellogg School of Management at Northwestern University. Mr. Mizutani is a member of the Board of Directors of Cosan Group, UNICA, the Brazilian sugar trade association, and Centro de Tecnologia Canavieria, a sugarcane research center in Brazil.

Codexis is a clean technology company. Codexis develops optimized biocatalysts that make industrial processes faster, cleaner and more efficient. Codexis' technology is commercialized with leading global pharmaceutical companies and in development for advanced biofuels with shell and carbon capture. Other potential markets for the company's biocatalyst-enabled solutions include chemicals and water treatment. For more information, see www.codexis.com.

Contacts:
Media: Lyn Christenson, lyn.christenson@codexis.com, 650.421.8144 or Saskia Sidenfaden, ssidenfaden@mww.com, 212.827.3771 Investors: Henk Adriaenssens, ir@codexis.com, 650.421.8331


'/>"/>
SOURCE Codexis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Codexis Reports Second Quarter 2011 Results
2. Codexis and Chemtex to Collaborate on Sustainable Detergent Alcohols for the Household Products Market
3. Codexis to Present at the Pacific Crest and Canaccord Genuity Conferences
4. Codexis to Present at 3 Investor Conferences in June
5. Codexis Achieves Development Milestones With Teva
6. Codexis to Present at Barclays Conference
7. Codexis to Announce First Quarter 2011 Financial Results on May 5, 2011
8. Codexis Names Jacques Beaudry-Losique VP Corporate Development & Strategy
9. Codexis Announces Carbon Capture Progress at ARPA-E Summit
10. Codexis Names David Anton CTO & SVP, Process Development & Manufacturing
11. Codexis to Present at the Jefferies and Pacific Crest Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2017)...  Amy Baxter MD, chief executive officer and founder ... relief, was awarded a 2017 Top 40 Healthcare Transformer ... at the MM&M Top 40 Healthcare Transformers dinner and ... on May 10, 2017. The dinner followed a full-day ... the pill."  "Innovation goes beyond invention," noted ...
(Date:5/10/2017)... Global Health Intelligence (GHI), the leading ... , published its 2017 ranking of the Best-Equipped Hospitals ... data analysis from GHI,s hospitals database for Latin America ... region. The GHI database covers 86% of the hospitals in ... data points for each institution in key areas such as ...
(Date:5/9/2017)... , May 9, 2017  Demonstrating its ... board of directors for the Pharmaceutical Research and ... for membership. Biopharmaceutical companies will now have to ... order to be eligible to join PhRMA. ... the board is sending a clear message that ...
Breaking Medicine Technology:
(Date:5/21/2017)... ... 2017 , ... Chris Cornell, 52, was found dead on the night of Wednesday, May 17, ... lead singers in the rock industry would take his own life, but the extremely talented ... mental illness played a role in the death of Chris Cornell . , Depression ...
(Date:5/21/2017)... (PRWEB) , ... May 20, 2017 , ... Pot. Reefer. ... find it, review it, and share its attributes like never before. More than a ... to connect cannabis enthusiasts to stores, strains, products – and for the first time ...
(Date:5/21/2017)... ... ... Following the tragic and widely publicized death of Rory Staunton, 12, from ... follow a protocol to quickly identify and treat the condition. , The mandate ... have saved Rory or anyone else’s life. , Now, five years after the ...
(Date:5/19/2017)... ... May 19, 2017 , ... ... an upcoming episode of Innovations with Ed Begley, Jr., airing fourth quarter 2017 ... distributor of a clean, organic dietary supplement made from naturally occurring ingredients. Innovations ...
(Date:5/19/2017)... ... May 19, 2017 , ... The Miller ... assistance to families and business owners in the region, is embarking on a ... sufferers and their families. , Multiple sclerosis (MS) is a demyelinating disease that ...
Breaking Medicine News(10 mins):